Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.13
WILYY's Cash to Debt is ranked lower than
94% of the 318 Companies
in the Global Medical Devices industry.

( Industry Median: 2.38 vs. WILYY: 0.13 )
Ranked among companies with meaningful Cash to Debt only.
WILYY' s 10-Year Cash to Debt Range
Min: 0.06  Med: 0.13 Max: No Debt
Current: 0.13
Equity to Asset 0.50
WILYY's Equity to Asset is ranked lower than
70% of the 280 Companies
in the Global Medical Devices industry.

( Industry Median: 0.66 vs. WILYY: 0.50 )
Ranked among companies with meaningful Equity to Asset only.
WILYY' s 10-Year Equity to Asset Range
Min: 0.11  Med: 0.26 Max: 0.5
Current: 0.5
0.11
0.5
F-Score: 6
Z-Score: 4.22
M-Score: -2.48
WACC vs ROIC
2.04%
16.75%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 18.84
WILYY's Operating margin (%) is ranked higher than
88% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. WILYY: 18.84 )
Ranked among companies with meaningful Operating margin (%) only.
WILYY' s 10-Year Operating margin (%) Range
Min: 18.84  Med: 20.75 Max: 32.26
Current: 18.84
18.84
32.26
Net-margin (%) 14.19
WILYY's Net-margin (%) is ranked higher than
86% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.99 vs. WILYY: 14.19 )
Ranked among companies with meaningful Net-margin (%) only.
WILYY' s 10-Year Net-margin (%) Range
Min: 12.7  Med: 14.75 Max: 17.71
Current: 14.19
12.7
17.71
ROE (%) 24.87
WILYY's ROE (%) is ranked higher than
95% of the 288 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. WILYY: 24.87 )
Ranked among companies with meaningful ROE (%) only.
WILYY' s 10-Year ROE (%) Range
Min: 24.92  Med: 99.74 Max: 163.08
Current: 24.87
24.92
163.08
ROA (%) 12.33
WILYY's ROA (%) is ranked higher than
89% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: -0.33 vs. WILYY: 12.33 )
Ranked among companies with meaningful ROA (%) only.
WILYY' s 10-Year ROA (%) Range
Min: 12.31  Med: 18.24 Max: 32.18
Current: 12.33
12.31
32.18
ROC (Joel Greenblatt) (%) 50.61
WILYY's ROC (Joel Greenblatt) (%) is ranked higher than
88% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 3.55 vs. WILYY: 50.61 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
WILYY' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 50.87  Med: 64.16 Max: 188.5
Current: 50.61
50.87
188.5
Revenue Growth (3Y)(%) 6.70
WILYY's Revenue Growth (3Y)(%) is ranked higher than
61% of the 193 Companies
in the Global Medical Devices industry.

( Industry Median: 3.00 vs. WILYY: 6.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
WILYY' s 10-Year Revenue Growth (3Y)(%) Range
Min: 6.4  Med: 9.85 Max: 15.4
Current: 6.7
6.4
15.4
EBITDA Growth (3Y)(%) 8.00
WILYY's EBITDA Growth (3Y)(%) is ranked higher than
61% of the 171 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. WILYY: 8.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
WILYY' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -1  Med: 12.50 Max: 18.4
Current: 8
-1
18.4
EPS Growth (3Y)(%) 5.00
WILYY's EPS Growth (3Y)(%) is ranked higher than
58% of the 171 Companies
in the Global Medical Devices industry.

( Industry Median: -1.60 vs. WILYY: 5.00 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
WILYY' s 10-Year EPS Growth (3Y)(%) Range
Min: -1.8  Med: 10.80 Max: 21
Current: 5
-1.8
21
» WILYY's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with WILYY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 21.70
WILYY's P/E(ttm) is ranked higher than
63% of the 156 Companies
in the Global Medical Devices industry.

( Industry Median: 29.20 vs. WILYY: 21.70 )
Ranked among companies with meaningful P/E(ttm) only.
WILYY' s 10-Year P/E(ttm) Range
Min: 12.03  Med: 25.59 Max: 40.08
Current: 21.7
12.03
40.08
Forward P/E 16.21
WILYY's Forward P/E is ranked higher than
74% of the 96 Companies
in the Global Medical Devices industry.

( Industry Median: 23.31 vs. WILYY: 16.21 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 21.70
WILYY's PE(NRI) is ranked higher than
64% of the 154 Companies
in the Global Medical Devices industry.

( Industry Median: 29.20 vs. WILYY: 21.70 )
Ranked among companies with meaningful PE(NRI) only.
WILYY' s 10-Year PE(NRI) Range
Min: 12.06  Med: 25.58 Max: 40.08
Current: 21.7
12.06
40.08
P/B 5.05
WILYY's P/B is ranked lower than
71% of the 288 Companies
in the Global Medical Devices industry.

( Industry Median: 3.18 vs. WILYY: 5.05 )
Ranked among companies with meaningful P/B only.
WILYY' s 10-Year P/B Range
Min: 4.26  Med: 18.76 Max: 68.81
Current: 5.05
4.26
68.81
P/S 3.08
WILYY's P/S is ranked higher than
51% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 3.11 vs. WILYY: 3.08 )
Ranked among companies with meaningful P/S only.
WILYY' s 10-Year P/S Range
Min: 1.91  Med: 3.81 Max: 7.09
Current: 3.08
1.91
7.09
PFCF 27.60
WILYY's PFCF is ranked higher than
59% of the 115 Companies
in the Global Medical Devices industry.

( Industry Median: 31.27 vs. WILYY: 27.60 )
Ranked among companies with meaningful PFCF only.
WILYY' s 10-Year PFCF Range
Min: 16.71  Med: 31.24 Max: 52.17
Current: 27.6
16.71
52.17
POCF 19.26
WILYY's POCF is ranked higher than
60% of the 149 Companies
in the Global Medical Devices industry.

( Industry Median: 22.43 vs. WILYY: 19.26 )
Ranked among companies with meaningful POCF only.
WILYY' s 10-Year POCF Range
Min: 12.43  Med: 21.91 Max: 35.14
Current: 19.26
12.43
35.14
EV-to-EBIT 18.13
WILYY's EV-to-EBIT is ranked higher than
64% of the 162 Companies
in the Global Medical Devices industry.

( Industry Median: 22.74 vs. WILYY: 18.13 )
Ranked among companies with meaningful EV-to-EBIT only.
WILYY' s 10-Year EV-to-EBIT Range
Min: 6.9  Med: 18.70 Max: 28.6
Current: 18.13
6.9
28.6
PEG 1.70
WILYY's PEG is ranked higher than
72% of the 53 Companies
in the Global Medical Devices industry.

( Industry Median: 3.24 vs. WILYY: 1.70 )
Ranked among companies with meaningful PEG only.
WILYY' s 10-Year PEG Range
Min: 0.79  Med: 2.23 Max: 10.71
Current: 1.7
0.79
10.71
Shiller P/E 25.58
WILYY's Shiller P/E is ranked higher than
65% of the 94 Companies
in the Global Medical Devices industry.

( Industry Median: 30.84 vs. WILYY: 25.58 )
Ranked among companies with meaningful Shiller P/E only.
WILYY' s 10-Year Shiller P/E Range
Min: 13.81  Med: 28.53 Max: 35.35
Current: 25.58
13.81
35.35
Current Ratio 0.78
WILYY's Current Ratio is ranked lower than
93% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.62 vs. WILYY: 0.78 )
Ranked among companies with meaningful Current Ratio only.
WILYY' s 10-Year Current Ratio Range
Min: 0.78  Med: 0.84 Max: 1.82
Current: 0.78
0.78
1.82
Quick Ratio 0.55
WILYY's Quick Ratio is ranked lower than
92% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.02 vs. WILYY: 0.55 )
Ranked among companies with meaningful Quick Ratio only.
WILYY' s 10-Year Quick Ratio Range
Min: 0.52  Med: 0.57 Max: 1.06
Current: 0.55
0.52
1.06
Days Inventory 167.68
WILYY's Days Inventory is ranked lower than
64% of the 280 Companies
in the Global Medical Devices industry.

( Industry Median: 130.93 vs. WILYY: 167.68 )
Ranked among companies with meaningful Days Inventory only.
WILYY' s 10-Year Days Inventory Range
Min: 157.55  Med: 167.69 Max: 256.59
Current: 167.68
157.55
256.59
Days Sales Outstanding 77.87
WILYY's Days Sales Outstanding is ranked lower than
58% of the 274 Companies
in the Global Medical Devices industry.

( Industry Median: 68.45 vs. WILYY: 77.87 )
Ranked among companies with meaningful Days Sales Outstanding only.
WILYY' s 10-Year Days Sales Outstanding Range
Min: 2.65  Med: 74.83 Max: 85.21
Current: 77.87
2.65
85.21

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 16.70
WILYY's Price/Tangible Book is ranked lower than
89% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. WILYY: 16.70 )
Ranked among companies with meaningful Price/Tangible Book only.
WILYY' s 10-Year Price/Tangible Book Range
Min: 15.11  Med: 28.97 Max: 152.09
Current: 16.7
15.11
152.09
Price/Projected FCF 1.71
WILYY's Price/Projected FCF is ranked higher than
61% of the 101 Companies
in the Global Medical Devices industry.

( Industry Median: 2.13 vs. WILYY: 1.71 )
Ranked among companies with meaningful Price/Projected FCF only.
WILYY' s 10-Year Price/Projected FCF Range
Min: 1.55  Med: 3.12 Max: 16.13
Current: 1.71
1.55
16.13
Price/DCF (Earnings Based) 1.66
WILYY's Price/DCF (Earnings Based) is ranked higher than
50% of the 16 Companies
in the Global Medical Devices industry.

( Industry Median: 1.66 vs. WILYY: 1.66 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 0.81
WILYY's Price/Median PS Value is ranked higher than
73% of the 243 Companies
in the Global Medical Devices industry.

( Industry Median: 1.11 vs. WILYY: 0.81 )
Ranked among companies with meaningful Price/Median PS Value only.
WILYY' s 10-Year Price/Median PS Value Range
Min: 0.63  Med: 0.92 Max: 1.48
Current: 0.81
0.63
1.48
Price/Peter Lynch Fair Value 2.11
WILYY's Price/Peter Lynch Fair Value is ranked lower than
54% of the 24 Companies
in the Global Medical Devices industry.

( Industry Median: 1.97 vs. WILYY: 2.11 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
WILYY' s 10-Year Price/Peter Lynch Fair Value Range
Min: 1.62  Med: 2.10 Max: 5.28
Current: 2.11
1.62
5.28
Price/Graham Number 3.98
WILYY's Price/Graham Number is ranked lower than
74% of the 125 Companies
in the Global Medical Devices industry.

( Industry Median: 2.37 vs. WILYY: 3.98 )
Ranked among companies with meaningful Price/Graham Number only.
WILYY' s 10-Year Price/Graham Number Range
Min: 3.6  Med: 5.52 Max: 14.59
Current: 3.98
3.6
14.59
Earnings Yield (Greenblatt) (%) 5.50
WILYY's Earnings Yield (Greenblatt) (%) is ranked higher than
81% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.80 vs. WILYY: 5.50 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
WILYY' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 3.5  Med: 5.40 Max: 14.4
Current: 5.5
3.5
14.4
Forward Rate of Return (Yacktman) (%) 13.24
WILYY's Forward Rate of Return (Yacktman) (%) is ranked higher than
80% of the 100 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. WILYY: 13.24 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
WILYY' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 4.6  Med: 13.20 Max: 17.7
Current: 13.24
4.6
17.7

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
Traded in other countries:0K7I.UK, WDH.Denmark, WDH.Germany,
William Demant Holding A/S is incorporated in Denmark. The Company is a hearing product and equipment manufacturer. The company operated in three segments namely Hearing Aids, Diagnostic Instruments, and Personal Communication. The Hearing Aid segment offers hearing aids under the Oticon and Bernafon brand names. Oticon offers several hearing aid lines, including EPOQ, Dual, Vigo, Hit, Sumo DM, and products for the elderly. Bernafon offers many hearing aid lines, including Verite, Icos, Brite, Move, Swissear, Symbio XT, Prio, Xtreme, Avanti, Neo, and Win. The products range from affordable to premium depending on the features needed. The Diagnostic Instruments segment includes Maico Diagnostics, Interacoustics, and Amplivox. Maico offers audiometers, middle ear analyzers, BERAphones, OAE test systems, software, and services. Interacoustics offer audiometers, middle ear analyzers, HA fitting, VNG balance systems, and rhiometry. Amplivox provides manual and automatic screening audiometers, audiogram software, diagnostic audiometers, acoustic booths, electro acoustic ear simulator, tympanometers, middle ear analyzers, spirometers, vision screeners, audiocups, and accessories and consumables. The Personal Communication segment operates under Phonic Ear and Sennheiser Communications. Phonic Ear offers sound field systems, teleloop and loudspeaker systems, infrared systems, and assistive listening devices.
» More Articles for WILYY

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
No related articles found.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK